Asad Wasi

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Asad Wasi is a biomedical engineer whose work sits at the intersection of drug delivery and medical robotics, pioneering non-invasive solutions for chronic disease management. His most impactful contribution is the development of a robotic pill for the oral delivery of biotherapeutics—a breakthrough that directly addresses the pain and compliance issues associated with lifelong injections. His landmark 2021 study, cited 94 times, demonstrated the safety, tolerability, and performance of this device in healthy subjects, offering a viable alternative to traditional parenteral routes for large-molecule drugs. By engineering a mechanism that protects biotherapeutics from gastrointestinal degradation, Wasi has opened a new frontier in oral biologics, potentially transforming treatment for conditions like diabetes and autoimmune disorders. His work represents a critical step toward replacing needles with ingestible robots, and his growing citation record reflects the field's recognition of this paradigm shift. For students and researchers, Wasi exemplifies how convergent engineering can solve one of pharma's most stubborn problems: making powerful therapies painless and patient-friendly.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago